OncoSec Medical to Present at Three Events in January
Jan 7, 2015 11:11:17 GMT
lcd, RLC, and 1 more like this
Post by JHam on Jan 7, 2015 11:11:17 GMT
ir.oncosec.com/company-news/detail/1724
OncoSec Medical to Present at Three Events in January
SAN DIEGO-- OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will present at three events in January. The Company’s agenda includes a number of high-profile scientific and investment conferences.
Biotech Showcase 2015
Punit Dhillon, President and CEO, will present a corporate overview of the Company at Biotech Showcase 2015, taking place January 12-14, 2015 in San Francisco, CA. The presentation is scheduled to begin at 9:00 AM PT on Tuesday, January 13.
At the time of the presentation, a live webcast will be available via the following link: edge.media-server.com/m/p/y67x6cc4.
OncoSec recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. After the presentation, an archived version of the webcast will be available for 90 days in the “Events” section of the OncoSec web page at www.oncosec.com.
Biotech Showcase™ provides biotechnology and life sciences companies with an opportunity to present to and meet with investors and pharmaceutical executives during the course of one of the industry's largest annual healthcare investor conferences. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies. For more information, please visit: www.ebdgroup.com/bts/index.php
An Introspective on Immunotherapy
OncoSec Medical will host “An Introspective on Immunotherapy: A Symposium on Intratumoral Therapy” on Tuesday, January 13 at the Palace Hotel in San Francisco, CA at 5:00 PM PT. The symposium will feature several key opinion leaders discussing the rationale and potential of intratumoral immunotherapy, and OncoSec’s role as a leader in this field.
After the symposium has concluded, a webcast will be made available via the following link: www.oncosec.com/jmp-immunotherapy-symposium-2015/
For more information or to RSVP, please contact Jordyn Kopin, Associate Director of Corporate Communications: jkopin@oncosec.com
Noble Financial Capital Markets 11th Annual Investor Conference
Jordyn Kopin, Associate Director of Corporate Communications, will present a corporate overview of the Company at Noble Financial Capital Markets’ 11th Annual Investor Conference. The conference will be held January 18-21, 2015 at Club Med, Sandpiper Bay, FL. For more information, please visit: www.nobleresearch.com/D2/2015.htm
OncoSec Medical to Present at Three Events in January
SAN DIEGO-- OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will present at three events in January. The Company’s agenda includes a number of high-profile scientific and investment conferences.
Biotech Showcase 2015
Punit Dhillon, President and CEO, will present a corporate overview of the Company at Biotech Showcase 2015, taking place January 12-14, 2015 in San Francisco, CA. The presentation is scheduled to begin at 9:00 AM PT on Tuesday, January 13.
At the time of the presentation, a live webcast will be available via the following link: edge.media-server.com/m/p/y67x6cc4.
OncoSec recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. After the presentation, an archived version of the webcast will be available for 90 days in the “Events” section of the OncoSec web page at www.oncosec.com.
Biotech Showcase™ provides biotechnology and life sciences companies with an opportunity to present to and meet with investors and pharmaceutical executives during the course of one of the industry's largest annual healthcare investor conferences. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies. For more information, please visit: www.ebdgroup.com/bts/index.php
An Introspective on Immunotherapy
OncoSec Medical will host “An Introspective on Immunotherapy: A Symposium on Intratumoral Therapy” on Tuesday, January 13 at the Palace Hotel in San Francisco, CA at 5:00 PM PT. The symposium will feature several key opinion leaders discussing the rationale and potential of intratumoral immunotherapy, and OncoSec’s role as a leader in this field.
After the symposium has concluded, a webcast will be made available via the following link: www.oncosec.com/jmp-immunotherapy-symposium-2015/
For more information or to RSVP, please contact Jordyn Kopin, Associate Director of Corporate Communications: jkopin@oncosec.com
Noble Financial Capital Markets 11th Annual Investor Conference
Jordyn Kopin, Associate Director of Corporate Communications, will present a corporate overview of the Company at Noble Financial Capital Markets’ 11th Annual Investor Conference. The conference will be held January 18-21, 2015 at Club Med, Sandpiper Bay, FL. For more information, please visit: www.nobleresearch.com/D2/2015.htm
